Impact of Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine on Malaria in Ugandan Schoolchildren: A Randomized, Placebo-Controlled Trial | Zendy

Joaniter I. Nankabirwa | Zendy; Bonnie Wandera | Zendy; Pauline Amuge | Zendy; Noah Kiwanuka | Zendy; Grant Dorsey | Zendy; Philip J. Rosenthal | Zendy; Simon J. Brooker | Zendy; Sarah G. Staedke | Zendy; Moses R. Kamya | Zendy

Open Access

Impact of Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine on Malaria in Ugandan Schoolchildren: A Randomized, Placebo-Controlled Trial

Author(s) -

Joaniter I. Nankabirwa,

Bonnie Wandera,

Pauline Amuge,

Noah Kiwanuka,

Grant Dorsey,

Philip J. Rosenthal,

Simon J. Brooker,

Sarah G. Staedke,

Moses R. Kamya

Publication year - 2014

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciu150

Subject(s) - medicine , parasitemia , malaria , anemia , placebo , incidence (geometry) , randomized controlled trial , asymptomatic , pediatrics , rate ratio , piperaquine , confidence interval , artemisinin , plasmodium falciparum , immunology , physics , alternative medicine , pathology , optics

Intermittent preventive treatment (IPT) in schoolchildren offers a promising option for malaria control. However, the optimal drug and dosing regimens for IPT remain to be determined.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research